Therefore, future investigations using KO models are warranted to test the hypothesis of whether or not CTRP13 indeed mediates vasoprotective effects and limits the development and progression of arteriosclerosis in vivo. This evidence concerns the gene C1QL3 and arteriosclerosis disorder.